STAT3 and neuroblastoma: Our findings suggest that CTTNBP2 CRE SNV1 decreased regulatory activity of CTTNBP2 CRE by reducing the affinity with STAT3, which acts as transcriptional activator of CTTNBP2 in NB cell lines.